The joint organization will provide care to about 115,000 patients each year in California, Arizona, Illinois and Georgia, according to a Feb. 2 City of Hope news release. It will employ more than 11,000 team members and 575 physicians.
Now that the acquisition has been completed, CTCA will transition into a nonprofit organization. CTCA President and CEO Pat Basu, MD, will report to City of Hope President and CEO Robert Stone.
“With the completion of this acquisition, City of Hope and Cancer Treatment Centers of America are combining complementary strengths, with a shared commitment to providing the best, most compassionate care possible,” Mr. Stone said. “Together, we are creating a new model for how cancer care is delivered, leveraging real-world cancer care experience to inform scientific innovation and making tomorrow’s new discoveries available to the people who need them today.”
The deal was first announced Dec. 8.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
